HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 25, No. 01, January 2021 – Home-Based Diagnostic Testing: Revolutionizing IBD Treatment       » Study Reveals Understanding of China’s Carbon Emission Balance       » Developing Nanomaterials for Better Performance       » Helping Farmers Monitor Plant Health and Improve Crop Yield       » Protecting the Brain through Gut-Trained Immune Cells       » Using Machine Learning to Predict Anti-Cancer Drug Efficacy      
Vol 21, No. 08, August 2017   |   Issue PDF view/purchase
EDITOR'S LETTER
We call this August issue “Eyes – the Window to your Soul”. The team behind APBN is honoured to invite Associate Professor Ian Yeo Yew San from Singapore National Eye Centre as our guest editor. In his article, he talks about the controlled environment of a clinical trial can never be replicated in a real life clinical setting due to limited resources. Clinical trials are cornerstones of evidence-based medicine (EBM) but they are only one of the components in the complex landscape of healthcare practice. You can read more on “Clinical Trials in our Real World”.

Age Related Macula Degeneration (AMD) is a common eye disease among people aged 50 and above. AMD, as suggested by its name, occurs due to the damage of macula, the most sensitive part of retina in our eyes. This eye condition can be classified into early, intermediate and advanced stage and is the leading cause for gradual vision loss in many older people. An article in Features, written by Dr Anna Tan, discusses the current and emerging diagnostic (imaging) and therapeutic developments in AMD. The significant developments in imaging for this disease include optical coherence tomography (OCT), fundus autofluorescence (FAF) and adaptive optics. Also check out the articles from other clinicians and scientists to learn more about the international collaborations done to address healthcare issues due to aging.

In Spotlights, APBN interviews Dr Allen Lai, the Senior Vice President of ACT Genomics, on how genetic testing can help in figuring customised and more effective treatment for cancer patients. We also feature several distinguished scientists from Commonwealth countries about agricultural biotechnology, stem cell research and burdens of malnutrition, respectively. If you are interested in robotics, it would be good to know that robots might be potentially used in eye surgery to help overcome challenges in ophthalmology in coming years.

Hope you enjoy reading APBN and take initiatives to protect and care for your eyes.

Thank you.


Carmen, Jia Wen Loh
APBN Editor
You can reach me at jwloh@wspc.com

 

You can always access all APBN's issues on our website: www.asiabiotech.com.
Check us out at Facebook @Asia Pacific Biotech News, Instagram @asiabiotech, or follow us on Twitter @asia_biotech.

 

NEWS CRUNCH  
news Highlights from the E&L China 2020 Conference
news Asia’s ageing population drives development of rehabilitation technologies targeting elderly disabilities
news Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market
news WEIPU, AstraZeneca, Huadong Medicine, Saint-Gobain, Baxter, Wuxi AppTec, Henlius, Medtronic and more confirmed to speak at E&L China this December
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy